Efficacy of Favipiravir Against Severe Ebola Virus Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Ebola Virus Disease
Interventions
OTHER

WHO-recommended therapies

symptomatic and supportive treatments according to the WHO manual

DRUG

Favipiravir

oral administration of Favipiravir tablets

All Listed Sponsors
collaborator

Beijing 302 Hospital

OTHER

collaborator

307 Hospital of PLA

OTHER

collaborator

Sierra Leone-China Friendship Hospital

UNKNOWN

collaborator

Centers for Disease Control and Prevention, China

OTHER_GOV

lead

Beijing Institute of Pharmacology and Toxicology

OTHER

NCT02662855 - Efficacy of Favipiravir Against Severe Ebola Virus Disease | Biotech Hunter | Biotech Hunter